Alexion ($23 billion, -3% YTD) is a pharma company best known for Soliris, a drug used to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria  two rare disorders. Alexion ($23 billion, -3% YTD) is a pharma company best known for Soliris, a drug used to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria  two rare disorders. You can find many such discontinuous pairs here. You can find many such discontinuous pairs here. See all Trefis Price Estimates and Download Trefis Data hereWhats behind Trefis?
Drug companies have done exceptionally well in setting up human drug markets.
( z0 well :ARG1 ( z1 set-up :ARG0 ( z2 company :mod ( z3 drug ) ) :ARG1 ( z4 market :mod ( z5 drug ) :mod ( z6 human ) ) ) :degree ( z7 exceptional ) )
(z0 / well-09
    :ARG1 (z1 / set-up-03
              :ARG0 (z2 / company
                        :mod (z3 / drug))
              :ARG1 (z4 / market
                        :mod (z5 / drug)
                        :mod (z6 / human)))
    :degree (z7 / exceptional))
Drug companies have done exceptionally well in setting up human drug markets .
z2 :mod z3
z0 :degree z7
z0 :ARG1 z1
z1 :ARG0 z2
z4 :mod z5
z4 :mod z6
z1 :ARG1 z4